Physician profile
Angela L Dabbs
NPI 1164437836
$1,799.14
in general payments reported to CMS, 2019-2025
16 companies · $647 in 2025
The $647 reported for 2025 was more than what 86% of Pediatrics (Optometrist) providers received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $114 · 2021: $113 · 2022: $119 · 2023: $106 · 2024: $526 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $416.95 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $222.99 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Abbvie INC. | $176.65 | 2024-2025 | |
| Topcon Healthcare, INC. | $160.57 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $150.42 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $141.37 | 2024-2025 | Acthar |
| Alcon Vision LLC | $114.87 | 2019-2025 | Rocklatan |
| Bausch & Lomb Americas INC. | $107.71 | 2022-2025 | Vyzulta, Miebo, Infuse |
| Aerie Pharmaceuticals, INC. | $91.04 | 2019-2021 | |
| Biotissue Holdings INC. | $74.44 | 2020-2024 | |
| Allergan, INC. | $51.41 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $28.46 | 2023 | Acuvue |
| Rxsight INC | $23.02 | 2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd) |
| Eyevance Pharmaceuticals LLC | $16.20 | 2019 | |
| Sun Pharmaceutical Industries INC. | $11.82 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Dabbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.